Cédric Panje
Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trial.
Panje C, Hayoz S, Eisterer W, Hess V, Thuss-Patience P, Schacher S, Dürr D, Wagner A, Girschikofsky M, Eboulet E, Stahl M, Ruhstaller T. Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trial. Eur J Cancer 2022; 177:186-193.
05.10.2022Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trial.
05.10.2022Eur J Cancer 2022; 177:186-193
Panje Cédric, Hayoz Stefanie, Eisterer Wolfgang, Hess Viviane, Thuss-Patience Peter, Schacher Sabina, Dürr Donat, Wagner Anna Dorothea, Girschikofsky Michael, Eboulet Eric I, Stahl Michael, Ruhstaller Thomas
Radiotherapy or Surgery? Comparative, Qualitative Assessment of Online Patient Education Materials on Prostate Cancer
Vu E, Pratsinis M, Plasswilm L, Schmid H, Panje C, Betschart P. Radiotherapy or Surgery? Comparative, Qualitative Assessment of Online Patient Education Materials on Prostate Cancer. Curr Oncol 2021; 28:3420-3429.
06.09.2021Radiotherapy or Surgery? Comparative, Qualitative Assessment of Online Patient Education Materials on Prostate Cancer
06.09.2021Curr Oncol 2021; 28:3420-3429
Vu Erwin, Pratsinis Manolis, Plasswilm Ludwig, Schmid Hans-Peter, Panje Cédric, Betschart Patrick
Creation of clinical algorithms for decision-making in oncology: an example with dose prescription in radiation oncology
Dennstädt F, Treffers T, Iseli T, Panje C, Putora P. Creation of clinical algorithms for decision-making in oncology: an example with dose prescription in radiation oncology. BMC Med Inform Decis Mak 2021; 21:212.
12.07.2021Creation of clinical algorithms for decision-making in oncology: an example with dose prescription in radiation oncology
12.07.2021BMC Med Inform Decis Mak 2021; 21:212
Dennstädt Fabio, Treffers Theresa, Iseli Thomas, Panje Cédric, Putora Paul Martin
Correction to: Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group
Ostheimer C, Dobiasch S, Arnold C, Oertel M, Haussmann J, Gauer T, Goy Y, Suess C, Ziegler S, Panje C, Baues C, Trommer M, Skripcak T, Billiet C, Thieme A, Kaul D, Mäurer M, Ebert N, Schmitt D, Krug D, Baumann R, Henkenberens C, Giordano F, Sautter L, López G, Fleischmann D, Niyazi M, Käsmann L, Medenwald D. Correction to: Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group. Strahlenther Onkol 2021; 197:560-561.
01.06.2021Correction to: Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group
01.06.2021Strahlenther Onkol 2021; 197:560-561
Ostheimer C, Dobiasch S, Arnold C R, Oertel M, Haussmann J, Gauer T, Goy Y, Suess C, Ziegler S, Panje Cédric, Baues C, Trommer M, Skripcak T, Billiet C, Thieme A H, Kaul D, Mäurer M, Ebert N, Schmitt D, Krug D, Baumann R, Henkenberens C, Giordano F A, Sautter L, López Guerra, Fleischmann D F, Niyazi M, Käsmann L, Medenwald D
Localized and Locally Advanced Prostate Cancer: Treatment Options
Achard V, Panje C, Engeler D, Zilli T, Putora P. Localized and Locally Advanced Prostate Cancer: Treatment Options. Oncology 2021; 99:413-421.
30.03.2021Localized and Locally Advanced Prostate Cancer: Treatment Options
30.03.2021Oncology 2021; 99:413-421
Achard Vérane, Panje Cédric, Engeler Daniel, Zilli Thomas, Putora Paul Martin
A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 expression in Switzerland
Barbier M, Pardo E, Panje C, Gautschi O, Lupatsch J, Swiss Group for Clinical Cancer Research (SAKK). A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 expression in Switzerland. Eur J Health Econ 2021; 22:669-677.
21.03.2021A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 expression in Switzerland
21.03.2021Eur J Health Econ 2021; 22:669-677
Barbier Michaela Carla, Pardo Esther, Panje Cédric, Gautschi Oliver, Lupatsch Judith Eva, Swiss Group for Clinical Cancer Research (SAKK)
Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group
Ostheimer C, Dobiasch S, Arnold C, Oertel M, Haussmann J, Gauer T, Goy Y, Suess C, Ziegler S, Panje C, Baues C, Trommer M, Skripcak T, Billiet C, Thieme A, Kaul D, Mäurer M, Ebert N, Schmitt D, Krug D, Baumann R, Henkenberens C, Giordano F, Sautter L, López G, Fleischmann D, Niyazi M, Käsmann L, Medenwald D. Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group. Strahlenther Onkol 2021; 197:385-395.
07.01.2021Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group
07.01.2021Strahlenther Onkol 2021; 197:385-395
Ostheimer C, Dobiasch S, Arnold C R, Oertel M, Haussmann J, Gauer T, Goy Y, Suess C, Ziegler S, Panje Cédric, Baues C, Trommer M, Skripcak T, Billiet C, Thieme A H, Kaul D, Mäurer M, Ebert N, Schmitt D, Krug D, Baumann R, Henkenberens C, Giordano F A, Sautter L, López Guerra, Fleischmann D F, Niyazi M, Käsmann L, Medenwald D
Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology
Iseli T, Plasswilm L, Sirén C, Schmidt B, Rothermundt C, Hundsberger T, Glatzer M, Panje C, Fischer G, Putora P. Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology. Oncology 2020; 98:438-444.
19.05.2020Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology
19.05.2020Oncology 2020; 98:438-444
Iseli Thomas, Plasswilm Ludwig, Sirén Charlotta, Schmidt Barbara, Rothermundt Christian, Hundsberger Thomas, Glatzer Markus, Panje Cédric, Fischer Galina, Putora Paul Martin
A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland
Panje C, Schwenkglenks M, Gautschi O, Plasswilm L, Aebersold D, Dedes K, Lorez M, Pardo E, Barbier M, Lupatsch J, Swiss Group for Clinical Cancer Research (SAKK). A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland. Ann Oncol 2020; 31:501-506.
16.01.2020A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland
16.01.2020Ann Oncol 2020; 31:501-506
Panje Cédric, Schwenkglenks M, Gautschi O, Plasswilm Ludwig, Aebersold D M, Dedes K J, Lorez M, Pardo E, Barbier M, Lupatsch J E, Swiss Group for Clinical Cancer Research (SAKK)
Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland
Bhadhuri A, Insinga R, Guggisberg P, Panje C, Schwenkglenks M. Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland. Swiss Med Wkly 2019; 149:w20170.
27.12.2019Cost effectiveness of pembrolizumab vs chemotherapy as first-line treatment for metastatic NSCLC that expresses high levels of PD-L1 in Switzerland
27.12.2019Swiss Med Wkly 2019; 149:w20170
Bhadhuri Arjun, Insinga Ralph, Guggisberg Patrik, Panje Cédric, Schwenkglenks Matthias
Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study
Panje C, Putora P, Hundsberger T, Hottinger A, Roelcke U, Pesce G, Herrmann E, Matter-Walstra K. Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study. Swiss Med Wkly 2019; 149:w20153.
02.12.2019Impact of treatment decision algorithms on treatment costs in recurrent glioblastoma: a health economic study
02.12.2019Swiss Med Wkly 2019; 149:w20153
Panje Cédric, Putora Paul Martin, Hundsberger Thomas, Hottinger Andreas F, Roelcke Ulrich, Pesce Gianfranco, Herrmann Evelyn, Matter-Walstra Klazien
Variations in radioiodine ablation: decision-making after total thyroidectomy
Maas O, Weidner S, Walter M, Schaefer N, Rottenburger C, Kneifel S, Kamel M, Haldemann A, Giovanella L, Engel-Bicik I, Brühlmeier M, Blautzik J, Panje C, Maas M, Forrer F, Putora P. Variations in radioiodine ablation: decision-making after total thyroidectomy. Eur J Nucl Med Mol Imaging 2019
09.11.2019Variations in radioiodine ablation: decision-making after total thyroidectomy
09.11.2019Eur J Nucl Med Mol Imaging 2019
Maas O, Weidner S, Walter M A, Schaefer N, Rottenburger C, Kneifel S, Kamel M E, Haldemann A, Giovanella L, Engel-Bicik I, Brühlmeier M, Blautzik J, Panje Cédric, Maas M, Forrer F, Putora Paul Martin
Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice
Panje C, Zwahlen D, Vees H, Reuter C, Pesce G, Papachristofilou A, Kaouthar K, Herrera F, Gomez S, Garcia Schüler H, Brouwer K, Arnold W, Pra A, Zilli T, Putora P. Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice. Radiat Oncol 2019; 14:177.
16.10.2019Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice
16.10.2019Radiat Oncol 2019; 14:177
Panje Cédric, Zwahlen Daniel, Vees Hansjörg, Reuter Christiane, Pesce Gianfranco, Papachristofilou Alexandros, Kaouthar Khanfir, Herrera Fernanda, Gomez Silvia, Garcia Schüler Helena I, Brouwer Kathrin, Arnold Winfried, Pra Alan Dal, Zilli Thomas, Putora Paul Martin
Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy
Panje C, Plasswilm L, Ruhstaller T, Gerard M, Hawle H, Schacher S, Henke G, Meier U, Garcia Schüler H, Herrmann E, Baracos V, Hayoz S, Höng L, Swiss Group for Clinical Cancer Research (SAKK). Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy. Radiat Oncol 2019; 14:166.
11.09.2019Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy
11.09.2019Radiat Oncol 2019; 14:166
Panje Cédric, Plasswilm Ludwig, Ruhstaller Thomas, Gerard Marie-Aline, Hawle Hanne, Schacher Sabina, Henke Guido, Meier Urs R, Garcia Schüler Helena, Herrmann Evelyn, Baracos Vickie E, Hayoz Stefanie, Höng Laura, Swiss Group for Clinical Cancer Research (SAKK)
Decision Making Criteria in Oncology
Glatzer M, Panje C, Sirén C, Cihoric N, Putora P. Decision Making Criteria in Oncology. Oncology 2018; Sep 18:1-9
12.12.2018Decision Making Criteria in Oncology
12.12.2018Oncology 2018; Sep 18:1-9
Glatzer Markus, Panje Cédric, Sirén Charlotta, Cihoric Nikola, Putora Paul Martin
Cost-effectiveness of nivolumab in the treatment of head and neck cancer
Hirschmann A, Lupatsch J, Schwenkglenks M, Panje C, Matter-Walstra K, Espeli V, Dedes K, Siano M, Swiss Group of Clinical Cancer Research (SAKK). Cost-effectiveness of nivolumab in the treatment of head and neck cancer. Oral Oncol 2018; 87:104-110.
30.10.2018Cost-effectiveness of nivolumab in the treatment of head and neck cancer
30.10.2018Oral Oncol 2018; 87:104-110
Hirschmann A, Lupatsch J E, Schwenkglenks M, Panje Cédric, Matter-Walstra K, Espeli V, Dedes K J, Siano Marco, Swiss Group of Clinical Cancer Research (SAKK)
Decision Making Criteria in Oncology
Glatzer M, Panje C, Sirén C, Cihoric N, Putora P. Decision Making Criteria in Oncology. Oncology 2018:1-9.
18.09.2018Decision Making Criteria in Oncology
18.09.2018Oncology 2018:1-9
Glatzer Markus, Panje Cédric, Sirén Charlotta, Cihoric Nikola, Putora Paul Martin
A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC)
Panje C, Lupatsch J, Plasswilm L, Aebersold D, Siano M, Gautschi O, Schwenkglenks M, Matter-Walstra K, Dedes K, Swiss Group for Clinical Cancer Research (SAKK). A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC). Radiother Oncol 2018; 129:257-263.
10.08.2018A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC)
10.08.2018Radiother Oncol 2018; 129:257-263
Panje Cédric, Lupatsch Judith E, Plasswilm Ludwig, Aebersold Daniel M, Siano Marco, Gautschi Oliver, Schwenkglenks Matthias, Matter-Walstra Klazien, Dedes Konstantin J, Swiss Group for Clinical Cancer Research (SAKK)
Assessment of pancreatic colloid carcinoma using F-FDG PET/CT compared with MRI and enhanced CT
Jiang L, Tang Q, Panje C, Nie H, Zhao G, Shi H. Assessment of pancreatic colloid carcinoma using F-FDG PET/CT compared with MRI and enhanced CT. Oncol Lett 2018; 16:1557-1564.
31.05.2018Assessment of pancreatic colloid carcinoma using F-FDG PET/CT compared with MRI and enhanced CT
31.05.2018Oncol Lett 2018; 16:1557-1564
Jiang Lei, Tang Qiying, Panje Cédric, Nie Hongting, Zhao Guochao, Shi Hongcheng
Treatment Options in Oncology
Panje C, Glatzer M, Sirén C, Plasswilm L, Putora P. Treatment Options in Oncology. JCO Clin Cancer Inform 2018; 2:1-10.
01.01.2018Treatment Options in Oncology
01.01.2018JCO Clin Cancer Inform 2018; 2:1-10
Panje Cédric, Glatzer Markus, Sirén Charlotta, Plasswilm Ludwig, Putora Paul Martin